A system that allows intracoronary delivery of blood "supersaturated" with oxygen after coronary stenting has received market approval from the US Food and Drug Administration (FDA), the developer, ...
In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.
The US Food and Drug Administration (FDA) has approved SuperSaturated Oxygen (SSO 2) Therapy to reduce infarct size in patients with left anterior descending (LAD) STEMI, the manufacturer, TherOx, ...
Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO 2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has been enrolled in the ...
A 34-year-old woman presented to the hospital after calling the emergency medical service (EMS) due to prolonged constrictive pain in her chest, which had come on suddenly at home. Records showed that ...
SAN FRANCISCO, CA – SEPTEMBER 21, 2009 – Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination ...
Medically reviewed by Christopher Lee, MDMedically reviewed by Christopher Lee, MD A widowmaker heart attack is a type of heart failure in which the heart's biggest artery, the left anterior ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results